Branford, CT, United States of America

Xiaojia (Sasha) Guo


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Xiaojia (Sasha) Guo: A Pioneer in Polypeptide and Nucleic Acid Development

Introduction: Xiaojia (Sasha) Guo is a notable inventor based in Branford, Connecticut, recognized for his significant contributions in the field of biotechnology. With a total of two patents to his name, Guo specializes in novel polypeptides and nucleic acids, aiming to enhance therapeutic and diagnostic methods.

Latest Patents: Guo's latest patents include "Polypeptides and nucleic acids encoded thereby" and "Proteins, polynucleotides encoding them and methods of using the same." The former patent discloses a series of novel polypeptides and the nucleic acids encoding them, alongside vectors, host cells, and antibodies that facilitate the production of these polypeptides and polynucleotides. His second patent outlines various nucleic acid sequences encoding distinct polypeptides, their corresponding polypeptides, and antibodies that specifically bind to these proteins. Furthermore, it details methods for diagnosis, treatment, and prevention of disorders associated with these innovative human nucleic acids and proteins.

Career Highlights: Guo works at Curagen Corporation, where he applies his expertise in biotechnology to spearhead research and development initiatives in the life sciences sector. His research has the potential to drive advancements in medical diagnostics and therapeutics.

Collaborations: Throughout his career, Guo has collaborated with esteemed colleagues, including Luca Rastelli and Carol E. A. Pena. Together, they work on innovations that push the boundaries of current scientific understanding and pave the way for new medical solutions.

Conclusion: Xiaojia (Sasha) Guo stands out as a prominent inventor in the biotechnology field, with a focus on developing novel polypeptides and nucleic acids that hold promise for therapeutic applications. His innovative contributions at Curagen Corporation and collaborative efforts with talented professionals highlight his commitment to advancing healthcare through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…